How a cardiovascular ASC expanded EP access in 2025

Advertisement

Amanda Ryan, DO, interventional cardiologist and CEO of the Carlsbad-based Advanced Heart and Vascular Center of New Mexico, joined Becker’s to discuss her center’s 2025 milestone of expanding access to advanced arrhythmia care by bringing electrophysiology services in-house. 

Editor’s note: This interview was edited lightly for clarity and length. 

Question: What’s something your ASC accomplished in 2025 that you’re especially proud of? How did you make it happen, and what lessons might be helpful to peers?

Dr. Amanda Ryan: As a single specialty rural cardiovascular ASC, we were successful in forming a partnership to bring electrophysiology services to our wide, underserved rural patient base. Atrial fibrillation and heart failure are epidemic, and our patients would routinely need to travel 3 to 4 hours for advanced care in these areas. 

Partnering with national leading electrophysiologists through an initiative focused on leveraging technology with physician skill to provide enhanced access to advanced arrhythmia care has been our major focus of 2025. This included a well-planned-out and dedicated training program over the past 6 months focused on creating workflows and staff education. It also coincided with the development of a focused atrial fibrillation clinic model to improve access and standardization of guideline based treatment options. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in Cardiology

Advertisement